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The Dorsal Raphe Nucleus (DRN) is a complex brain region that has been 
implicated in disorders such as anxiety and depression. The DRN is divided into 
subregions through its rostrocaudal and mediolateral axis. It has been reported that after a 
single restraint session there is differential spatial activation of nitric oxide synthase 
(NOS) across the DRN. The temporal profile of NOS activity during acute stress is not 
known but it is important because duration of acute stress is associated with different 
general responses. In this report rats were restrained for 1, 3, or 6 hours and nicotinamide 
adenine phosphate diaphorase (NADPH-d) was stained as an index to NOS activity to 
determine the spatial-temporal profile of NOS throughout a 6 hour restraint.  Astrocyte 
reactivity was also measured to determine whether NOS activation correlated with GFAP 
expression since astrocytes react to neural activity and store and release l-arginine, the 
precursor for nitric oxide production. The results showed that the DRN had a dynamic 
response to acute restraint stress, most notably in the caudal lateral wings where 
activation increased after 3 hours of restraint (p = > 0.001) but neuron count decreased 
ii 
after 6 hours (p = 0.040).  Astrocytes did not correlate with NOS activation but they 
showed spatial-temporal differences as well whereas they were more active in the rostral 
half of the DRN. In conclusion, the present study suggests that NOS produced in the 
DRN may have a role in prolonged exposure to acute stress and that subregions show 
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Virtually every person has had to deal with some form of stress in their lifetime. 
Stress is a physiological or physical altercation which results in an interaction between 
neuronal and endocrine systems and ultimately results in the production of 
glucocorticoids from the adrenal glands. The process for this is termed “flight or fight” 
response. “Flight or fight” is a mechanism our bodies use to cope with situations that are 
deemed life threatening.  The fight or flight response is triggered when a stressful 
stimulus activates the hypothalamic-pituitary-adrenal (HPA) axis, in particular, the 
paraventricular nucleus (PVN) of the hypothalamus, the anterior lobe of the pituitary 
gland, and the adrenal gland. Corticotropin releasing factor (CRF), the primary regulator 
of the HPA axis is released from the PVN. CRF reaches the anterior pituitary and triggers 
the release of adrenocorticotropic hormone (ACTH).  ACTH then targets the adrenal 
cortex where the production of glucocorticoids, cortisol in humans and corticosterone in 
rodents, is stimulated and ultimately released. Constant stimulation of the fight or flight 
response is often associated with depression.1 
Depression from overstimulation of the HPA axis stems from disruptions in 
neurotransmitters involved in mood regulation. For example CRF links stress and 





The DRN is the major source of 5HT in the brain and it is highly implicated in 
anxiety disorders and depression.3-6  However, at least 50% of the DRN is non-
serotonergic with a large portion of NO producing neurons which have a unique 
topographical distribution and colocalization pattern across the DRN.7 
The most common class of antidepressants is serotonin specific reuptake 
inhibitors (SSRI) such as Paxil, Prozac, and Zoloft. SSRI’s function by blocking 
receptors called reuptake receptors on the presynaptic neuron and astrocytes that would 
take up the neurotransmitter after a signal has been transmitted. Blocking 5-HT reuptake 
receptor maintains 5-HT in the synaptic cleft, and it continues binding to the postsynaptic 
receptor, transmitting a signal. Some classes of serotonin and norepinephrine reuptake 
inhibitors, such as Effexor, suppress nitric oxide as secondary mode of action. Studies 
show that the presence of nitric oxide synthase (NOS) inhibitors have antidepressant 
effects.8  The problems with current antidepressants are: (1) less than 50% of patients 
show full remission, (2) there is possible increase of suicidal tendencies, and (3) it has no 
effect in about 40% of patients.9  So it is necessary to develop new drug targets and 
understanding the role of NO in the pathogenesis of acute stress may help identify NO as 




The dorsal raphe nucleus (DRN) is a topographically unique brain region that is 
functionally organized into distinct subregions based on the localization of serotonin (5-
HT) neurons. The subregions are divided into rostrocaudal and mediolateral dimensions. 





nucleus contains the densest population of 5HT neurons in the brain there is a large non-
5HT domain which includes NOS neurons.10  Similar to 5HT, NOS neurons maintain a 
unique topographical distribution and colocalization pattern across the DRN.7  
Nitric Oxide synthase (NOS) neurons have been found to colocalize with 
tryptophan hydroxylase (TPH), the enzyme that produces 5HT, across the midline of the 
DRN in approximately 75% of cells. In contrast, NOS does not colocalize with TPH in 
the lateral wings of the DRN, but there is evidence of 5HT receptors colocalizing with 
NOS.11-12  Also, recently it has been revealed that the NOS cells in the most caudal lateral 
wings colocalize with cholinergic cells of the lateral dorsal tegmental.12  NOS neurons in 
the caudal lateral wings are highly implicated in the stress response.  Acute restraint 
stress shows differential NOS activation across subregions of the DRN where the rostral 
ventromedial region and caudal lateral wings were the most activated.13  Meanwhile, 
NOS produced in the DRN plays a role in antidepressant-like and anxiolytic-like 
effects.14 
These studies combined with the present study provide evidence that the caudal 
lateral wings are an important component in how the DRN processes stress information.  
Here we will add that there is a differential temporal response especially in the lateral 




Restraint stress increases NOS activation in several brain areas including the 
DRN. Previous studies showed a significant increase of NOS activity in the DRN 





regions where NOS is independently localized from serotonin. Other areas of the brain 
that show differences in NOS activation are the paraventricular nucleus of the 
hypothalamus and the supraoptic nucleus of the hypothalamus. Both display a significant 
increase of NOS activation at 3 hours then a decrease at 6 hours. There is also evidence 
that NO produced in the DRN is involved in antidepressant-like behavior.16 
Duration and modality of restraint has varying effects on the rat brain and 
behavior.  Rats that are exposed to single episode of an hour restraint may show signs of 
anxiety or depression up to 24 hours later. 
The objective of this experiment is to reveal NOS activation patterns in the DRN 
in a spatial-temporal manner. Astrocyte density is analyzed because it is a possible source 
for NOS to obtain arginine; therefore, increased reactivity of astrocytes may correlate to 
NOS activation. 
The hypothesis of this study is that NOS activation and GFAP expression will be 
differentiated throughout the DRN as stress is processed over a 6 hour length of restraint 
stress.  
1.4 Research Questions 
 
1. What is the spatial-temporal profile of NADPH-D in the DRN in response to 
acute stress?   









1.  Nitric Oxide synthase activation is differentiated in a spatial-temporal manner 
in the dorsal raphe nucleus.  
2.  Astrocytic density will be a reflection of NOS activation. 
 
1.6 Specific Aims 
 
Objective 1: Demonstrate that NOS activation is differentiated in a spatial-
temporal manner. 
Specific Aim 1: Determine the pattern of NOS activity in the dorsal raphe 
nucleus in response to increasing lengths of restraint stress. Using NADPH-d 
to determine NOS activation within the topography of the DRN will reveal the 
pattern of NOS activity in each subregion at different lengths of restraint. 
Specific Aim 2: Determine differences in the spacing of swellings on nitrergic 
axons of the DRN following different lengths of restraint stress.  Nitric oxide 
diffuses out of the cells as soon as it is produced therefore it uses nonsynaptic 
release. However, nonsynaptic release through varicosities allows for a 
summation of NO. An increase in intervaricosity density may provide evidence 
that there increased NO being released from fibers projecting to the DRN.  This 
aim will provide evidence on how varicosity axons of the DRN change in 
response to stress by measuring inter-varicosity distance for each region and 
compare the mean spacing. Studying the fibers will show whether a particular 





there is a difference in intervaricosity space in stressed rats compared to non-
stressed rats.   
Objective 2: Demonstrate the pattern of astrocyte activity in the DRN following 
different durations of restraint stress. 
Specific Aim 3: Determine whether astrocytes respond to acute stress in the 
DRN and if there are differences in expression throughout the DRN 
Since astrocytes have been shown to be reactive in stress signaling, here we will use 
antiGFAP to stain astrocytes and observe/measure differences in astrocytic reactivity 





 LITERATURE REVIEW 
 
 
2.1 Dorsal Raphe Nucleus 
 
The dorsal raphe nucleus (DRN) is a heterogeneous brain structure containing 
axons that modulate all levels of the brain and therefore is implicated in a variety of 
functions. It extends from the nucleus of Edinger Westphal, through the pons, and into 
the rostral portion of the medulla at the level of the tegmental nuclei. In the horizontal 
plane it is between the cerebral aqueduct and fourth ventricle and extends ventrally 
between the trochlear nuclei and medial longitudinal fasciculi (Figure 1).  The nucleus 
has a role in sleep, antidepressant, anxiolytic effects, and transmission of  
nociception.14, 17-19  It is a neurochemically complex structure that accounts for about 40-
50% of serotonin (5-hydroxytryptamine, 5-HT) production in the brain.  The DRN is 
anatomically defined by clusters of 5-HT-containing cells which run in a rostral-caudal 
manner.3 These clusters create subdivisions, which are: dorsomedial (DRD), 
ventromedial (DRV), and bilateral (lateral wings) sub-regions (DRL) (Figure 2). Given 
that the DRN is responsible for most of the brain’s serotonin and it innervates all levels of 
the brain, the main function of this region was once thought to release 5-HT to all levels 
of the brain at the same time.  However, there is a large non-5HT domain of the DRN, 






                                    
                                          
Figure 1. Paxino and Watson Adaptation of Dorsal Raphe Nucleus.  The dorsal raphe 
nucleus (images adapted from Paxinos and Watson rat brain atlas) Coronal sections: (a) 
Bregma -6.3mm, (b) Bregma -8.3mm, (c) Bregma -9.3mm.  Horizontal section with DRN 
between aqueduct and 4th ventricle. The dorsal raphe nucleus is distinguished by the 
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Figure 2. Caudal dorsal raphe nucleus. 5x objective image of NADPH-d stained neurons 
in the caudal dorsal raphe nucleus. Red arrows point to the lateral wings, red circle is the 
dorsal region, red triangle surrounds the ventral region. 
 
These neurochemicals may interact with serotonin by co-localizing in the same 
neuron or may act independently of serotonin.15, 20  As a matter of fact at least 70% of 
neurons in the midline co-express NOS and 5-HT but nitrergic neurons in the caudal 
lateral wing are completely independent of 5-HT (Figure 3).7, 15  Furthermore, subregions 
of the DRN are differentially activated in response to stimuli and produce different 
responses depending on the region activated. For example mid-caudal parts of the DRN 
are involved in anxiety processing while the DRL subregion is responsive to panic-







Figure 3. Serotonin and nNOS in the DRN. Okere and Waterhouse 15 showed serotonin 
and nNOS localization in the DRN. Serotonin (red) co-localizes with nNOS (green) in the 
rostral midline but the caudal DRN shows complete independent localization of nNOS 
and serotonin 
 
Also in response to acute stress, studies report that the caudal-DRL exhibits more 
nitrergic neural activity than the rostral-DRL while the rostral DRD and DRV show more 
nitrergic neural activity than their respective caudal regions.15  These findings may be due 
to the fact that the subdivisions have different paths for their axonal projections.  
DRN divisions are important because each subregion sends axons to different 
parts of the brain.  The rostrally located DRD and DRV regions project largely to cortical 
structures while the lateral wings project only to subcortical structures.7, 22  These 
subcortical structures include the thalamus, hypothalamus and amygdala, which are 
involved with sleep and attention, stress regulation, and emotions and fears, respectively. 






and virtually none from the rostral DRN.23  However, neocortical regions, like the 
temporal lobe, receive significantly denser projections from the rostral DRN than the 
caudal DRN.23  Dorsal raphe cells that give rise to cortical projections are clustered in 
three distinct rostral to caudal groupings, such that neurons projecting to motor, 
somatosensory, and visual cortices are concentrated in the dorsomedial, suprafascicular 
ventromedial, and interfascicular ventromedial subregions of the DRN, respectively. 
Generally, the rostral midline DRN is associated with motor functions and has specific 
connections to the caudate–putamen, basal ganglia, striatum, and motor cortex 23-28 
whereas the caudal midline regions are implicated in stress and anxiety responses.4, 26, 29 
Lastly, the DRN is important in mood regulation and psychological disorders. Its 
size and 5-HT component are different among several mental health disorders. In major 
depressive disorder the area of the DRN is decreased, bipolar disorder is characterized by 
a decreased size serotonergic neurons, and suicide is characterized by an increased DRN 
area and higher density but decreased size of serotonergic neurons.30   
2.2 Physiological Nitric Oxide  
 
Nitric Oxide (NO) is a diffusible gas synthesized from L-arginine by nitric oxide 
synthase (NOS) (Figure 4). There are three isoforms of NOS; neuronal NOS (NOSI or 
nNOS), endothelial NOS (eNOS, or NOSIII), and inducible NOS (iNOS or NOSII).31 
The amino acid sequence homology between the subtypes is less than 59% in the same 
species and higher than 80% for the same subtype between species.31  iNOS is normally 







Figure 4. Synthesis of NO from Arginine. Synthesis of NO from l-arginine by NOS 
schematic by Aurelio et al., 2009 . Following an increase in calcium concentrations, 
calmodulin binds to NOS and activates it. L-arginine is oxidized to NO and citrulline in 
the presence of 4 other co-factors including NADPH which is also oxidized to NADP+. 
Once NO is produced it diffuses out of the cell and binds to guanylyl cyclase (GC) where 
cGMP is ultimately produced.  
 
Unlike nNOS and eNOS, iNOS tightly binds calmodulin and its activity is 
calcium independent.31  It is stimulated in response to cytokines or microbial agents and 
plays a role in the inflammatory response.32  Inducible NOS is also involved in stress 
induced depression.  In fact, after 4 weeks of an unpredictable chronic mild stress there is 
increase in iNOS expression in the cortex.33 
eNOS is constitutively expressed and generally found in the endothelium of blood 
vessels. It produces NO that is responsible for blood vessel dilation via binding to the 
heme group of guanylyl cyclase and increasing cGMP production.31  
nNOS is generally localized in neurons of the central and peripheral nervous 
system, it is also constitutively expressed, binds guanylyl cyclase, and increases cGMP 
production. nNOS activation is induced by increases in intracellular calcium levels, 






motif to bind to NMDA receptor.31  When glutamate binds to NMDA receptor it 
subsequently activates nNOS by increasing intracellular calcium.31  
 Unlike other neurotransmitters, NO diffuses out of a neuron upon its synthesis 
and binds directly to its target cell. Therefore, it can use both synaptic and nonsynaptic 
transmission. It also acts retrogradely on a presynaptic cell from a postsynaptic cell while 
most neurotransmitters cannot.35   
Detecting NO is difficult because it is highly reactive and has a short half-life. 
Therefore, the localization and activation of NOS is widely used in studies. NADPH-
diaphorase histochemical technique is used based on the fact that all NOS enzymes 
contain a binding site for NADPH-d and display diaphoretic activity (Figure 5).31  So 
NADPH-d is a widely accepted marker for NOS activity. In fact, early studies show that 
in both brain and peripheral tissue NOS and NADPH-d are identical.36  Nitroblue 
tetrazolium is the substrate that binds to NADPH-d which reduces tetrazolium to a blue-
black formazan in the presence of NADPH. Therefore, the more active enzymes in a 
neuron the more formazan will be produced and the more intense the blue-black stain. 
Other techniques to detect NOS are immunohistochemistry antibodies raised against each 
isoform, cDNA or cRNA probes to determine expression of their respective mRNAs, 
and/or assays that measure L-citrulline, cGMP, nitrites, and nitrates.31  
As a neurotransmitter, Nitric Oxide (NO) acts a modulator and has been linked to 
memory, learning, and antidepressant affects.16, 37  It may act as a reuptake inhibitor for 








Figure 5. Various types of varicose fibers in caudal DRL. Red arrows indicate 
varicosities on axons. 
 
Neurotransmitter uptake by nerve endings is a mechanism of inactivation for 
many released neurochemicals, such as dopamine, glutamate, and serotonin, hence the 
reason most antidepressants block the uptake of 5-HT.38  Nitric Oxide also potentiates the 
role of neurotransmitters. It does this for GABA in the medulla oblongata by acting on 
the presynaptic neuron.39  By NO increasing GABA activity it has an inhibitory role 
because GABA is an inhibitory neurotransmitter. 
Nitric Oxide is able to shut down both NOS activation and expression through a 






(ferrous) or oxidized (ferric) and both ferric- and ferrous-nitrosyl complexes exist with 
NOS, which leads to inhibition .41  nNOS largely employs inhibition by ferrous-nitrosyl 
complex regardless of the NO concentration (70-90%).42  For all NOS, a loss of activity 
appears when heme binds NO that accumulates in a solution as a consequence of 
chemical equilibrium.43   NO is able to inhibit NOS expression for both eNOS and 
iNOS.44 
2.3 Nitrergic Neurons and Nitric Oxide Activity 
 
NO plays a regulatory role in the stress response. It is highly expressed in the 
HPA axis where it modulates the release of ACTH and corticosterone.31  Furthermore 
NOS activation is increased in the HPA axis following stressful stimuli.31  In depression 
NO production increases and inhibition of NO production has antidepressant like 
effects.45-46   
Previous studies show that nitrergic neurons co-localize with 5-HT in the rostral 
dorsal and rostral ventral regions of the DRN but are independent of 5-HT in the caudal 
lateral wings (Figure 3).15  Acute restraint stress increases NOS activation in all 
subregions of the DRN but most significantly in the caudal DRL.15  It was also shown 
that NO produced in the DRN has antidepressant-like and anxiolytic-like effects.16 
Spiacci Jr. showed that when L-Arg was injected into the DRN, it significantly increased 
anxiolytic-like behavior and an L-arginine inhibitor produced anxiety-like and 
depressant-like behaviors. In general though, it has been shown that inhibitors of nNOS 
induce antidepressant-like effects in animal models and a 2012 study concluded that 






models.8, 33, 47-48  All together this shows that NO produced in the brain has different 
effects depending on where it is produced and that NO produced specifically in the DRN 
lateral wings may play a role in antidepressant and anxiolytic behaviors.  
Besides depression and anxiety behaviors, NO has been implicated in 
schizophrenia and bipolar disorder.49-50  Postmortem brain sections show an increase in 
NOS concentrations in the cerebellum of schizophrenic patients and overall NOS activity 
was higher in platelets of drug naïve schizophrenic patients compared to healthy 
individuals and drug-treated schizophrenic patients.51-52  Patients with bipolar disorder 
have higher levels of nitrites in their plasma compared to healthy patients.47 
NO is involved with sleep regulation so there is no surprise that its concentration 
is on a circadian cycle. In various brain regions NOS activity was highest during the dark 
period and lowest in the light period. More specifically, the hypothalamus had highest 
NOS activity between 3:00 pm and 3:00 am.53 
Nitrergic efferents of the DRN are a topic that needs further exploration, but with 
at least 70% of midline cells co-expressing both 5HT and NOS it is likely that 5HT 
projections and NOS projections of this region are the same. This is especially evident in 
the spinal cord and forebrain where 80% of 5-HT neurons also contain NOS. In contrast, 
in descending spinal cord regions 5-HT neurons do not contain NOS.7  Nitrergic only 
neurons have been reported to project to the barrel field cortex of the trigeminal pathway, 
70-80% of those neurons coming from the midline, and 30-40% of DRL neurons project 
to the ipsilateral ventral posteromedial nucleus of the thalamus (VPM), and the 






lateral wing projections are solely to subcortical structures and there are functional 
topographical differences of the DRN.  
Other brain regions besides the DRN where NOS is present include the 
hypothalamus. In the hypothalamus NO regulates the release of several hormones 
including CRH. It is involved in the hypothalamic-pituitary response to cytokines. 
Cytokines are induced by lipopolysaccharides and viral products. Interleukin-2 activates 
nNOS and NO induces the release CRH. The presence of NOS and the role of NO in the 
hypothalamus is important because this is a region where the DRN projects axons and 
previous studies have also showed that restraint stress alters NOS activity in the 
hypothalamus.  
2.4 Dorsal Raphe and Varicose Fibers 
 
Just as the DRN projects to all levels of the brain it also receives input from all 
levels of the brain. The DRV and DRL both receive input from the same brain regions 
however the lateral wings received some inputs from brain regions that the DRV does not 
Some of the regions that project to the DRV and DRL are: anterior perifornical nucleus, 
ventral part of the nucleus of the stria terminalis, lateral preoptic area, paraventricular 
nucleus of the hypothalamus, lateral and posterior hypothalamus, periventricular region 
of the third ventricle, ventral tegmental area, dorsolateral periaqueductal gray, 
pedunculopontine tegmental nucleus, laterodorsal tegmental nucleus, medial parabrachial 
nucleus, dorsomedial and ventrolateral tegmental areas in pons, median raphe and raphe 
magnus nuclei, gigantocellular nucleus, lateral paragigantocellular nucleus, prepositus 






nucleus of the solitary tract. The DRL also has a unique set of projection fibers which are 
the diagonal band of Broca, rostral DRN, lateral parabrachial nucleus, caudal most 
pontine gray medial to the genu of the 7th nerve and medial vestibular nucleus. 7 The 
paraventricular nucleus of the hypothalamus is noteworthy because it is the main 
component of the hypothalamus involved with the stress response and other autonomic 
functions and it projects to both the DRV and DRL.  
The characteristics of incoming fibers are important because they give 
information like relative signal transmission speed and how neurotransmitters are 
released. Thick axon fibers tend to increase conductance and therefore offer faster 
transmission over longer distances than thin fibers.54  Some axons have fibers that have 
the appearance of beads on a string; those beads are called varicosities or axon boutons 
(Figure 5).  
Varicosities allow for neurotransmitters to be released before they reach the 
synapse, therefore release is nonsynaptic. These varicosities are up to 2 µm in diameter 
and about 3 µm in length and similar to traditional synapses, are packed with vesicles and 
mitochondria.55  Varicosities contain neurofilaments and the distance between them 
called intervaricosity distance can be as little as 0.2 µm.55  The inter-varicosity distance is 
important for several reasons. The mean spacing between varicosities is a reflection of 
synaptic density and varicosity density along the axon can be an index of localized 
neuronal interactions.56  Information about varicosities is important for drug discovery 
because they allow for release of transmitters outside of a synapse and therefore allow for 
binding to high affinity extra synaptic receptors.57  The midbrain periaqueductal gray 






displays an increase in varicose axons as well as a decrease in distance between 
varicosities on an axon.58 
NO, as mentioned earlier, uses both nonsynaptic and synaptic forms of 
transmission. Varicosities are beneficial for NO release because it provides multiple 
sources for NO to be released. When NO is released from multiple sources with a 
distance of <200 µm from each other it summates and diffuses at a further distance than it 
would from a single source.59 
2.5 Stress 
There are several types of psychological stress including; acute stress and chronic 
stress.  Chronic stress is a debilitating type of stress that may stem from childhood 
trauma. It is a daily occurrence and people who experience it often cannot see a way out 
of their situation which they view as miserable.60 Acute stress is momentary and comes 
from past or future events. Some symptoms of acute stress are: emotional distress, 
muscular problems, heartburn and other stomach problems.60 An example of acute stress 
would be getting in a car accident or planning for a big event. Acute stress may also 
transition to chronic stress. For instance an individual being laid off at work is an acute 
stress situation, but when the job search is prolonged it could lead to chronic stress.  Also 
other more serious types of acute stressors such as experiencing death could trigger 
emotions such as depression, irritability, and anxiety. All of these examples of stressful 
events trigger the HPA axis response.  
Stress may also help worsen or increase risk of conditions such as obesity, 






with stress which may be triggered by either chronic or acute stressors. When a person is 
overly stressed it leads to over activity of the HPA axis, reduced serotonin, and increased 
NO production amongst a host of other differences.64  An overactive HPA axis leads to 
increased levels of cortisol and impaired feedback regulation. Receptors for cortisol 
become desensitized which leads disturbances in neurotransmission. 
Restraint stress is an uncontrollable stress situation that influences changes in 
behavioral and autonomic responses, like mean arterial pressure and heart rate increase.65 
Restraint stress induces anxiety and depressive like behaviors in rats.  Animals exposed 
to restraint stress showed decreased exploratory activity in an open field, increased 
immobility in a forced swimming test, and reduced exploration of the open arms of an 
elevated plus maze.66-67  The psychological and physical changes associated with restraint 
come from distress and aversive nature of having to remain immobile.   
Some papers use immobilization while others use restraint as techniques to induce 
stress.  The difference between restraint and immobilization is that immobilization limits 
range of locomotion without inhibiting movement of specific limbs. An example of 
immobilization is putting an animal in a restraint device, leaving room for their head and 
tail, the limbs are free but the area is too small for the animal to move about.  An example 
of restraint is taping an animal’s limbs to a board or pad, so that movement restriction is 
placed specifically on the limbs.68 
A single episode of restraint is considered a model for acute stress. Chronic stress 
is modeled by consecutive days of being restrained, so a 1 hour restraint for 7 days is an 
example. The length of time an animal is in restraints corresponds to different behaviors, 






increase in ACTH levels, increase in corticosteroid levels, and an increase in anxiety 
behavior. 2-5 hours of restraint correspond to an increase in ACTH response, decreased 
level of activity and exploration, decrease in spatial memory, and increase in 
hippocampal NO, while 6 or more hours shows dendritic retraction, decreased spatial 
memory, and decreased reward related motivation.68 Although just a 15 minute restraint 
is long enough to induce ACTH and corticosterone secretion, decrease food intake, 
increase CRF, and increase neuron activity.69-71 
Restraint stress effects NOS activation in other brain regions.  In the 
paraventricular nucleus (PVN) and supraoptic nucleus (SON)  of the hypothalamus, NOS 
activation is significantly increased after a 3 hour restraint but after 6 hours of restraint 
there is significant decrease.72  The periaqueductal gray showed significant increases in 
the number of varicosities on axons and NOS activation following a 3 hour restraint.58 
2.6 Astrocytes 
 
Astrocytes are a type of glia that plays many roles in the brain. They are the most 
abundant type of cell found in the central nervous system. The various roles of astrocytes 
include assisting with neural signaling, reuptake and breakdown of neurotransmitters 
from the synaptic cleft, maintain ionic homeostasis in microenvironment, and provide 
neurons with nutrients. Astrocytes were originally organized into two distinct 
morphological categories, fibrous astrocytes or protoplasmic. Fibrous astrocytes have 
many extended processes and are located primarily in white matter.73 Protoplasmic 
astrocytes have many short branched processes and are found mainly in gray matter.73  






regions. For example in the olfactory bulb layers, which are anatomically and 
functionally distinct, there is a differential distribution of astrocyte morphology subtypes. 
More specifically, there were 6 subtypes identified: unipolar, irregular, wedge-shape, 
circular, semicircular, and elongate.74  These subtypes are characterized by the shapes of 
their processes, the extension of their processes, and the overall astrocyte shape. The 
presence of different morphological types in functional distinct layers of the olfactory 
bulb suggests that astrocyte morphology is important and may have functional relevance.  
Astrocytes are important in neural signaling in that they participate in 
neurotransmitter reuptake and breakdown and may provide transmitters to both 
postsynaptic and presynaptic cells.75  Reuptake receptors on the astrocyte are an 
important function of synaptic regulation. When a neuron is fired into the synaptic cleft 
reuptake receptors take up neurotransmitters that do not bind to postsynaptic receptor, 
which effectively stops the signal from transmitting any further.  
Astrocytes have structures on their processes called endfeet, which surround 
blood vessels in the brain. Endothelial cells of the blood brain barrier form very tight 
junctions, which only small molecules such as O2 and CO2 can cross. Larger molecules 
are regulated through various transport systems. Glucose passes through on GLUT 
transporters and neutral amino acid on L1 amino acid transport system.76-77 
2.7 Astrocyte Plasticity 
Astrocytes express glial fibrillary acidic protein (GFAP) which is an intermediate 
filament cytoskeletal protein; it is also a marker for reactive astrocytes. Astrocytes often 






an increase in the number and size of cells expressing GFAP.78  GFAP may be necessary 
for the formation of stable glial processes in response to neuronal signals. Changes that 
occur in reactive astrocytes may also be a reflection of increase in astrocyte metabolism 
and protein synthesis as a response to changes in the microenvironment.79  Evidence 
shows that the transition of astrocytes from resting to activation is associated with the 
expression of new molecules not normally detected in resting astrocytes and upregulation 
of molecules normally present in low levels.  For example after facial motor neuron 
injury astrocytes express NADPH-d and there is increased NO production.80  Increase in 
the cytoskeleton proteins, GFAP may assist with wound repair by either helping to 
strengthen the tissue surrounding injury or glial scarring may help form a wall to prevent 
neuronal injury from spreading or help form a barrier to hinder regenerating neurites 
from growing out.79  
Changes in GFAP expression have been associated with chronic stress and 
depression. Animals exposed to activity stress for 6 consecutive days showed an increase 
in GFAP expression in the hippocampus.81  While in human and rat’s depression is 
marked by a decrease of GFAP expression in the limbic region.  
2.7 Arginine Transport 
 
The brain gets arginine from 4 major sources which are: (1) From the blood 
transported to brain tissue through the blood brain barrier (BBB); (2) It may come from 
the cerebral spinal fluid transported through the choroid plexus ependymal cells; (3) It 







Arginine is recycled from citrulline in many cells.  There are two enzymes that 
must be present in order for recycling to take place.  Citrulline and aspartate are used by 
argininosuccinate synthetase (ASS) to form argininosuccinate. Argininosuccinate is then 
cleaved by argininosuccinate lyase (ASL) to form arginine.84  Immunohistochemical 
experiments showed differential expression of ASS and nNOS neurons and many NOS 
neurons did not contain both, like NOS neurons of the periaqueductal gray. There was 
some colocalization for example neurons in the dorsolateral tegmental area contained 
both nNOS and ASS.85  In situ hybridization showed co-localization of both ASS and 
ASL in all nNOS neurons.84   
Arginine from the BBB is obtained by astrocytes via a family of transporters that 
facilitate the transport of cationic amino acids called y+ transport system. The y+ 
transport family consists of three types of cationic amino acid transporters (CAT). The 
transporters are responsible for the transport of arginine, lysine, and orthinine across the 
BBB.82  The 4 CA transporters are: CAT-1, CAT-2A, CAT-2B, and CAT-3 each 
differently expressed in rat brain cells.86,87  CAT-1 is expressed in neurons, astrocytes, 
oligodendrocytes, and endothelial cells, CAT2B is in neurons and oligodendrocytes, and 
CAT-3 is detected in neurons only.88 
Astrocytes act as a site of storage and mediator between arginine and neurons.89-90  
In fact, nitrergic fibers and endothelial cells are often localized adjacent to arginine 
positive astrocytes.91 
 Given that arginine is stored and released from astrocytes where nitrergic 
containing cells are in close proximity the proposed model for glia-neuron interaction 






NMDA glutamate receptors, after it is released it is transported to NOS containing 
neurons via y+ transport system where it is utilized by NOS to produce NO (Figure 6).92  
               
Figure 6. NOS-Glia interaction .Arginine transport by y+ transport system following 











The animals were cared for per the Morehouse School of Medicine Internal 
Animal Care and Use Committee (IACUC). They were housed in a climate controlled 
environment. The restraints used were specifically designed to accomplish research goals 
that are unmanageable or impractical to accomplish by any other means. Provisions were 
made for observation of the animals at appropriate intervals. The animals had access to 
food and water except when restrained. 
3.1 Animal Care Statement 
  
Male Long Evans rats were maintained in the local animal facility under standard 
environmental conditions and had unlimited access to rodent chow pellets and water. 
Experimental and control rats were age- and weight- matched because of age dependent 
variables in endogenous NOS activity. The experiments conformed to the local and NIH 
regulations guiding the use of experimental animals for scientific investigation.  
3.2 Study Design 
Twenty four (24) Long Evans rats were used for this study. Their weights were 
between 170-200 grams which is associated with age 45-50 days.  The animals were 




6 hours. The unrestrained rats serve as the control. The restraints were conducted 
between 9:00 am and 3:00 pm when nitric oxide synthase activity is at a low point during 
its circadian rhythm. 
3.3 Description of the setting 
 
Rats were housed in a climate controlled environment and acclimated to their new 
environment for a week prior to restraints. A regular 12/12 light cycle was used and food 
and water were provided ad libitum. 
3.3.1 Transcardial Perfusion 
 
After restraints rats were anesthetized with isoflurane and perfused with 4% 
paraformaldehyde (PFA) to preserve the brain tissue. Toe pinch reflex was used to 
determine when the anesthetic has worked. While the rat was being anesthetized the 
perfusion apparatus was set up. The infusion pump was prepared with two 1 liter glass 
beakers. One beaker contained phosphate-buffered saline (PBS) and the other contained 
4% PFA fixative in 0.1 M PBS. Controlled release of a valve allowed PBS to flow 
through a tube into an attached hypodermic needle that was connected to the infusion 
pump. The needle was placed in the left ventricle of the rat’s heart and the right atrium 
was punctured to allow blood to escape. The animals were then decapitated and the brain 
was collected and post fixed overnight at 4◦C followed by immersion in 30% sucrose 





3.3.2 Brain Sectioning 
 
Each brain was mounted on a removable cryostat platform. Tissue-Tek® 
Optimum cutting temperature (O.C.T.) formulation embedding medium (Sakura Fineteck 
USA, Inc., Torrance, CA 90501 USA) for frozen tissue specimen was used to ensure 
most favorable sectioning environment, to add additional firmness, and to preserve the 
structure and shape of the brain tissue to facilitate the cutting process. At room 
temperature, a small amount of Tissue-Tek ® was placed on the cryostat (Micron 
International, HM 500 OM) platform. The brain/Tissue-Tek ® complex was placed in an 
auxiliary holding corridor inside the cryostat and allowed to freeze to a temperature of 
about -20◦C. Once this temperature was reached, the platform with the brain attached was 
placed on the main cryostat corridor. The brains were cut in the coronal plane in an 
anterior or posterior direction into sections 20 microns thick. The sections were collected 
in 12 1ml microtubes with cryoprotectant.  
3.4 Tissue Staining 
 
3.4.1 NADPH-d for NOS Activation 
 
Tissues are prepared by washing 3x with PBS in a 24 well plate, floating sections 
were stained with NADPH-d (incubated in0.1 M PBS, pH 7.4, containing 0.3% Triton-X-
100, 0.1 mg/ml nitroblue tetrazolium and 1.0 mg/ml NADPH) overnight in a 37◦C 
incubator. Following incubation the sections were washed 3x at 5 minutes each in PBS 
and mounted on gelatin-subbed microscope slides using free-floating tissue mounting 




alcohol and xylene the sections were cleared and dehydrated. Permount mounting 
medium was used to cover slip the slides.  
3.4.2 Astrocyte IHC 
 
Using an ABC staining kit from vector labs sections were incubated for 45 
minutes with diluted normal blocking serum and excess was blotted from sections. They 
were then incubated overnight with anti-GFAP antibody diluted in PBS (1/100). Washed 
in buffer for 5x2 minutes then incubated for an hour with diluted biotinylated secondary 
antibody. Then washed again for 5x2 minutes in PBS and incubated with ABC reagent 
for 30 minutes then rinsed for 5x2 minutes in PBS. Finally, the tissues were incubated for 
30 minutes in diluted AMCA for blue fluorescent staining.  
3.4.3 Image Acquisition  
  
The DRN was divided into 6 subregions for immunohistochemical analysis. In the 
rostrocaudal dimension: rostral (-7.3 to -7.73 mm Bregma and caudal (-8.45 to -9.26mm 
Bregma). For each dimension every 4th coronal section was obtained and stained.  
A Zeiss microscope fitted for either AxioCamMR3 for RGB or AxioCAMMR3 
for black and white was used for all images. Axio imaging software was used to capture 
all images. Images were taken at 10-fold objective and 20-fold objective.  The exposure 
time for all fluorescence imaging was 906.0 ms at 100% 
 
3.4.4 Image Processing 
 
All image processing was done with ImageJ.  Three (3) sections for each rostral-




intervaricose spacing for 5 rats and the mean for each rat for each experimental group and 
brain region was obtained.  Neuron counts were done manually on 10-fold objective 
images by placing a ticker while ImageJ kept count. Optical density (OD) was calculated 
from the mean gray value measured by ImageJ.  Mean gray value is the sum of the gray 
values of all the pixels in the selection divided by the number of pixels. As mentioned 
previously NADPH-d staining intensity is an indicator of how active a neuron is. An 
intense stain in a neuron is indicated by the dark coloring produced by the conversion of 
tetrazolium to formazan. So the optical density is a relative indicator of how active the 
NOS in a neuron is. The higher the OD the more active the NOS is in a given neuron 
compared to neurons with low ODs. Optical density measurements were taken on 20-fold 
objective images and the mean is of a collection of single neurons in the each subregion.  
The minimum criterion to be included in the assessment of varicosity spacing was 
for a nitrergic process to have at least three sequential varicosities at least 5 varicosities 
were measured per region.  Images for varicosities were intentionally taken in areas 
where varicose fibers were the highest.  
 GFAP expression was measured by an automated ImageJ count of the number of 
astrocytes and fibers expressed; 20-fold objective images were converted from RGB to 
16-bit, then a threshold was set to cover all the astrocytes and fibers. Only particles of an 
area of >150 pixels and a circularity of 0.00-1.00 were counted.  
NOS expression was counted using automated ImageJ counting on control and 6 




circularity were counted. The pixel sizes for GFAP and NOS counts were selected by 






RESULTS AND DATA 
 
 
There were varying levels of activated neurons which is denoted by the intensity 
of NADPH-d staining. The more active the neuron the darker the NADPH-d stain (Figure 
7 and Graph 1). 
 
Figure 7. Various types of NADPH-d staining intensity. Staining intensities in the caudal 
DRN show various levels of NOS activity; (a) represents low activity in the DRD, (b) 










Graph 1. NADPH-d intensity measured by optical density of pixels. (a) Neurons from 
the dorsal region, (b) neurons from the ventral region, and (c) neurons from the lateral 
wings.  
 
As well-known, NOS neurons in the DRN localize mostly to the rostral dorsal, 
rostral ventral, and caudal lateral wings (Figure 8). NOS activity in the lateral wings 
increases as the dorsal raphe nucleus becomes more caudal (Graph 2). However the 
opposite is evident for the dorsal and ventral regions where activity and expression 
decreases as the DRN becomes more caudal (Graph 2). The caudal lateral wings have the 





                                
                       










Figure 8. NOS activity in the (a) Rostral and (b) Caudal sub-regions.  Notice the Caudal 








Graph 2. NOS activity in each DRN sub-region. Caudal lateral wing has the most NOS 
activation compared to all other sub-regions. 
 
4.1 Lateral Wings 
 The lateral wings showed no significance in the number of activated neurons 
between control (rostral mean = 8, SEM = 1.50, caudal mean = 66, SEM = 2.77), 1 hour 
(rostral mean = 12, SEM = 1.78, p-value = .097, caudal mean = 68, SEM = 7.03, p-value 
= .660), and 3 hour (rostral mean =11 SEM = 1.84, p-value = .081, caudal mean = 69, 
SEM = 4.25, p-value = .962) restraint for either rostral or caudal. There is significance at 
6 hour caudal (caudal mean = 52, SEM = 4.73, p-value = 0.040, rostral mean = 5, SEM = 
1.26, p = 0.098) restraint where there is decrease in the number of activated neurons 







    
Graph 3. Caudal DRL show 21% decrease in the number of active neurons. 
  
 Although NOS activity decreased in neurons the expression did not change 
between control (mean = 69, SEM = 5.08) and hours (mean = 65, SEM= 3.67, p = 0.211) 







  * 





                                            
 
                              




   6 hour 





Graph 4. NOS expression did not change between control and 6 hour restraint.  
 
Optical density measurements showed differences in NOS activation. A 1 hour 
restraint displayed a 57% increase in the OD of neurons in the rostral DRL but there was 
no difference in the caudal DRL (rostral mean = 1.44, SEM = 0.098, p = -.019, caudal 
mean = 2.06, SEM = 0.192, p- = 0.198) compared to the control (rostral mean = .912 
SEM = 0.100). A 3 hour restraint in the rostral DRL did not show any differences (mean= 
1.16 SEM = 0.176, p = 0.877) but neurons in the caudal DRL showed a 28% increase in 
OD compared to the control (mean = 2.58 SEM = .013, p = > 0.001). Finally, 6 hours of 
restraint showed no differences in either rostral (mean = 1.13 SEM=0.177 p = .285) or 






Graph 5. Optical Density of the DRL. In (a), rostral show a 57% increase following 1 
hour of restraint; in (b) caudal, there is 28% increase in NOS activity. 
 
 




Immunofluorescence as well as NADPH-d staining displayed more varicose 
fibers in the caudal lateral wings than any other region (Figure 10).  
 
              a.           b.     
                 c.          d.    
                 e.           f.   
Figure 10. Varicosity fibers in the DRN 40-fold objective stained for NADPH-d,  
varicosity fibers in rostral vs caudal subregions. NADPH-d stained fibers. The caudal 
lateral wing (f) has the most varicose fibers than other regions. 
 
A 1 hour restraint did not show any differences in the rostral DRL (mean = 7.80 
µm SEM = 1.147, p = .249) compared to the control (mean = 7.59 µm SEM = 1.747) of 
the same region.  The caudal DRL showed a significant decrease in intervaricosity 




























































spacing (mean =7.23 µm SEM = 0.517, p< 0.001). Restraint for 3 hours did not change 
the intervaricosity distance in the rostral DRL (mean = 8.60 µm SEM = 1.373, p=.401). 
However, intervaricosity distance decreased in the caudal DRL of 3 hour restraint (mean 
= 6.61 µm SEM = 0 .798 p< .001); 6 hour restraint did not show any differences in 
intervaricosity distances for either region (rostral mean = 7.93 SEM = 1.749, p = 0.740, 
caudal mean = 9.41 µm SEM = 1.33, p = .381) (Graph 6).  
 
 
Graph 6. Inter-varicosity distance measurement for fibers in the lateral wings. This graph 
compares each time point with the corresponding region in the control. 
 
The restraint rats also showed more thin fibers than those of the control in the 
caudal DRL (Figure 11). 
 
 





Figure 11.  20 fold objective images of varicosity axons in the caudal DRL. Restraint 
animals showed thinner varicose types compared to the control animals.  
 
4.2 Ventral 
The ventral region did not have any significance in mean number of cells at any 
length of restraint (control: rostral mean = 56, SEM = 9.93, caudal mean = 16, SEM = 
4.04, 1 hour: rostral mean = 58, SEM = 8.91, p =.538, caudal mean = 19, SEM=2.56, p = 
0.589, 3 hour: rostral mean = 64, SEM = 6.82, p = .747, caudal mean = 18, SEM = 4.10, 
p = 0.397, 6 hour: rostral mean = 66, SEM = 10.75, p = 0.562, caudal mean = 20, SEM = 













































   
   
   
   
   









































NOS activity did not show any changes in rats restrained for 1 hour (rostral  
mean = 1.48, SEM = .082, p = 0.681, caudal mean = 1.08, SEM = 0.154, p = 0.384) 
compared to controls (rostral mean = 1.44, SEM = 0.185, caudal mean = 1.01, SEM= 
0.131). A 3 hour restraint increased activity in the rostral (mean = 2.15, SEM = 0.127, p = 
0.024) but not the caudal region (mean = 1.34, SEM = .245, p = 0 .286).  Finally, 6 hours 
of restraint showed similar differences as 3 hours of restraint, there was increase in the 
rostral region (mean = 2.01, SEM = .122, p = .029) but not the caudal region (mean = 
1.47, SEM = .204, p = .072) (Figure 12 and Graph 7).  
 
 
Figure 12. NOS activation in the Rostral Ventromedial.  
 
                             Control                                                               1 hour 





Graph 7. NOS Activity in the DRV. NADPH-d staining revealed increased staining 
intensity following 3 hour and 6 hour in the rostral DRV.  
 
By observation this region had the least amount of varicose fibers in both rostral 
and caudal end, but there were differences in the spacing on the fibers present (Figure 
12). The rostral and caudal regions showed differences in the intervaricosity distance at 1 
hour (rostral mean = 4.18 µm, SEM = 2.00, p = .042, caudal mean = 4.49 µm, SEM = 
1.98, p = .020).  A 3 hour restraint also showed decreased varicose spacing in both rostral 
and caudal regions (rostral mean = 4.19 µm, SEM= 0.771, p = 0.001, caudal mean = 4.49 
µm, SEM =.984, p<.001). There was also significant decrease in varicose spacing 6 hour 
caudal region (caudal mean = 4.21 µm, SEM = 0.329, p<.001) but not the 6 hour rostral 
region (rostral mean = 4.95 µm, SEM = 1.20, p = .154 (Figure 13 and Graph 8).  
 
 






















Figure 13.  Astrocytes in the rostral DRN. 20-fold objective of astrocytes in the rostral 
DRN AntiGFAP Immunofluorescence with AMCA revealed a 50% increase of GFAP 
expression in restraint rats.  
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Graph 8. There were differences in varicosity spacing at all lengths of restraint.  In the 
rostral region (a) there was 31% decrease at 1 hour and 3 hour restraint but no changes in 
6 hour restraint.  The Caudal region showed 37% decrease for 1 and 3 hour restraint and 
40% decrease for 6 hour restraint.  
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The mean number of cells in the dorsal region did not change between 1 hour 
(rostral mean = 16 +/- 4.407, p =.418, caudal mean = 6 +/- 2.64, p = .197) and 3 hour 
(rostral mean = 6.1 +/- .989, p-value = 0.301, caudal mean = 16 +/- 1.557, p = 0.261) 
restraint compared to the control (mean = 15 +/- 2.52). Restraint following 6 hours 
displayed a significant increase in the number of active neurons (rostral mean = 22 +/- 
3.02, p = 0.043, caudal mean = 2.88).   
Optical density measurements showed a 28% decrease in NOS activity in the 
rostral DRD of rats restrained for 1 hour (mean = 1.17 +/- 0.073, p = 0.005) compared to 
the control (mean = 1.568 +/- 0.128) but no changes in the caudal DRD (mean = 1.13 +/- 
0.144, p = 0.119).  Restraint following 3 hours did not show any significance in either 
rostral (mean = 1.85 +/-0.138, p= 0.169) or caudal (mean = .846 +/- 0.066, p = 410).  A 6 
hour restraint also did not change the OD in the rostral (mean = 1.73 +/- 0.162, p = 0.686) 
or caudal region (mean = 1.09, SEM = 0.162, p = 0 .410). 
Varicose measurements were not changed in the dorsal region for following 1 
hour of restraint in either region. However varicosity spacing decreased in the caudal 
DRL following 3 hours and 6 hours of restraint (1 hour: rostral mean = 7.49 µm, SEM= 
1.77, p = .145, caudal mean = 8.04 µm , SEM= 1.21, p = .589, 3 hour: rostral mean = 
5.65 µm, SEM = 1.43, p = .747, caudal mean = 7.37 µm, SEM = 1.21, p = .040, 6 hour: 
rostral mean = 6.63, SEM = 1.28, p = .372, caudal mean = 7.27, SEM = 1.50, p = .033) 
compared to the control (rostral mean = 6.09 µm, SEM = 0.868, caudal mean = 9.13 µm, 






There was no correlation between GFAP expression and NOS activity in either 
the rostral, caudal region or their respective sub regions (total rostral region: r = 0.02, p > 
.05, total caudal region = r = .108, p>.05).  
Restraint increased the number of GFAP astrocytes in the total DRN at all levels 
(control mean = 50, SEM = 13.38, 1 hour mean = 66, SEM = 15.24, p = .007, 3 hour 
mean = 63, SEM = 5.51, p = 0.011, 6 hour mean = 72, SEM = 17.58 p <0.001). The most 
significant differences were in the rostral DRN because all lengths of restraint showed 
increases in astrocytic density in that region (control mean = 47, SEM = 13.37, 1 hour 
mean = 75, SEM = 15.96, p>0.001, 3 hour mean = 67, SEM = 16.97, p = 0.006, 6 hour 
mean = 69, SEM = 18.71, p = .005) (Graph 8). The caudal region did not display 
differences until 6 hours of restraint (control mean = 50, SEM = 12.04, 1 hour mean = 50, 
SEM = 15.24, p =.391, 3 hour mean = 55, SEM = 10.83, p = .340, 6 hour mean = 75, 






























Figure 14. Astrocytes in the caudal DRN. GFAP antibody staining with AMCA reveals 
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5.1 Lateral Wings 
 
 The lateral wings are the region where NOS neurons localize 
independently of 5-HT neurons and NOS activation is the most significant. 
Restraint stress did not have an effect on the mean number of neurons in the lateral wings 
in rats that were restrained for up to 3 hours. However, there was a decrease in the 
number of NADPH-d positive cells following 6 hours of restraint.  The decrease is an 
indicator of decrease in NOS activation but not expression because measuring NOS 
neurons following NOS-1 antibody did not show changes in NOS expression.  This 
suggests that there is some mechanism that is causing NOS activation to shut down 
following 6 hours of restraint.   
Optical density which is an indicator of relative NOS activation was significantly 
increased in the caudal and rostral lateral wings. Specifically a 1 hour restraint increased 
rostral DRL activity and 3 hour restraint increased caudal DRL activity. 6 hour restraint 
did not show any differences in either rostral or caudal DRL activity besides a decrease in 
number of activated neurons.  
The DRL only projects to subcortical structures. Since the caudal lateral wings are 
most activated at 3 hours of restraint one may assume that the DRN is highly involved 





restraint. Some of the subcortical regions that could be receiving nitrergic neurons from 
the DRN are the hypothalamus and amygdala. More specifically evidence shows that 
non-5HT neurons project to the basal forebrain and amygdala.93  There is also evidence 
that shows approximately 30-40% of neurons from the DRL that project to the trigeminal 
system are nitrergic.22  Further experiments need to be done to show an extensive 
projection path of DRL nitrergic cells. 
By observation the caudal region displayed the most significant number of 
nitrergic fibers and varicose fibers than any other subregion. So fibers that project to the 
DRN had the most significant differences in the caudal region. Restraint decreased the 
spacing between varicosities in the caudal region but not the rostral region. 1 hour and 3 
hour displayed decreased spacing between varicosities.  6 hours did not display any 
differences in varicosity spacing compared to the control. All levels of restraint displayed 
thinner varicose fibers than those in the control rats. That is suggestive that the fibers 
activated during restraint are different from those in nonrestraint rats.  
Afferent fibers of the DRN include extensive input from various regions of the 
hypothalamus, medullary regions, and medial prefrontal cortex.94  The highest density of 
these projections are in the DRV and DRL subregions.94 In the total DRL region there 
were no significant differences in the number of GFAP expressing cells until 6 hours of 
restraint.  
 
5.2 Ventral  
 
The ventral region contains the most NOS neurons compared to all of other 





differences in the number of NOS activated cells in the ventral region, NOS activity 
increased in the caudal DRV at 3 hours and 6 hours of restraint.   
By observation the DRV had the least amount of varicose fibers than the DRL and 
DRD but displayed significant differences in mean spacing between varicosities in all 
lengths of restraint compared to the control. The rostral region showed differences up to 3 
hours of restraint but no significant differences at 6 hours of restraint.  The caudal region 
showed differences at all lengths of restraint.   
Along with the DRL, the DRV receives dense fibers from the hypothalamus; 
whether these fibers are exactly nitrergic is not clear. However it is a possibility given 
that the pattern of NOS activation in the hypothalamus is consistent with a lack of 
differences in the varicose spacing of nitrergic neurons during 6 hours of restraint also the 
thin fibers of the ventromedial were similar to the fibers seen in the lateral wings.72 
Even though the ventral region displayed the least amount of GFAP expression 
than the other subregions, the total ventral region showed increased GFAP at all lengths 
of restraint in each rostro-caudal region.   
 
5.3 Dorsal 
The dorsal region contains the least amount of NOS neurons compared to all other 
regions. Stress by restraint increased the number of NADPH-d positive cells at 6 hours of 
restraint.   
Following 1 hour of restraint there was a decrease in the OD of NADPH-d 





distances did not show any differences between controls and restraint either. GFAP 
expression was significant at 6 hours of restraint in the total DRD.  
 
5.4 Temporal Changes in the DRN  
 
This study supports evidence that as the DRN processes stress it is using different 
populations of nitrergic neurons as evident by the differential activation of subregions 
and differences in the fiber types in each subregion. The temporal changes of NOS in the 
DRN have never been reported. Here it is shown that the DRN nitrergic neurons are 
differentially activated in each region at different time points throughout a 6 hour 
restraint. It also supports the notion that the DRN is involved in processing a prolonged 
exposure to stress, rather than the quick response as seen in fight or flight. 
It has been shown that rats restrained for a single hour display behavior that 
indicates depression for up to 24 hours, this study showed the least changes in the DRN 
compared to the control following 1 hour of restraint (Figure 15). There were changes in 
intervaricosity distance in the lateral wings which continued through 3 hours of restraint, 
which may suggest the activation of a different set of neurons projecting to the DRN in 








Figure 15. Timeline of events throughout 6 hour duration of acute restraint stress in the 
Dorsal Raphe Nucleus.  
 
  Three (3) hours of restraint showed the most activity of NOS being that both the 
caudal DRL and rostral DRV were significantly activated which are the regions with the 
most expressed NOS neurons compared to the dorsal region. Three (3) hours of restraint 
also decreased mean spacing between varicosities and showed. This is a crucial time 
point during the stress response for NOS activation in the DRN.  It is also consistent with 
unpublished data that NOS activation is significantly increased in other brain regions 
following a 3 hour restraint compared to control, 1 hour, and 6 hour restraint.  The 





could be involved with the increase in activation, as well as an increase in regulation by 
neuronal localized CAT-3 but not CAT-1.  
  The most interesting finding is the decrease in NOS activation in the caudal DRL 
following 6 hours of restraint. The changes from 3 hours to 6 hours suggest a change in 
the response to stress, even though the stressor has not changed.  The decrease here is 
also consistent with decreases seen in the hypothalamus PVN and SON.72  The PVN 
projects fibers to the DRL which may be a reason there is not significant differences in 
inter-varicosity distances after 6 hours of restraint compared to the control.  It would also 
be interesting to see the activation of GABAergic fibers in the DRN following 6 hours of 
restraint.  If there is an increase it may also explain the reason NOS is so lowly activated 
here. 
 
5.5 DRN Fibers  
 
Fibers of the DRN provide another source of NO.  NO from these fibers may 
interact with the nitrergic neurons in the region but they may also interact with other 
types of neurons in the region such as the 5-HT neurons or cholinergic neurons.  Since 
NO can act retrogradely on a presynaptic cell this NO may be interacting with other 
fibers that synapse in the DRN and influence the release of those other neurotransmitters.  
GABAergic and Glutamatergic fibers also innervate the DRN which provide 
inhibitory and excitatory activity, respectively. NO is known to block the reuptake of 
glutamate which is how it is involved with LTP. It interacts with GABAergic cells. If NO 
is interacting with either one of these fiber types then it could be modulating its own 





NO diffusion from varicosities is an advantage because it allows for a big release 
of NO from one region.  NO has a short half-life so in order for a signal to constantly be 
transmitted by NO, a cell has to constantly make NO until there is no longer a need for 
the signal.  Varicosities have the potential to release a lot more NO than a straight axon 
so that the amount of NO meets the need to transmit a signal.  
5.6 Differential GFAP Expression in the DRN 
Increased GFAP is an indicator of astrocyte reactivity.  It usually occurs as a 
response to neural injury and is found in neurodegenerative diseases. However, here there 
is increase in GFAP expression in neurons of animals that had a single episode of 
restraint.  It has been reported that increased GFAP may be a reflection of an increase in 
metabolism and protein synthesis as a response to changes in the environment. Increased 
activity of the DRN may be the reason for increased GFAP expression during stress.  
Although the differences of the DRN did not correlate with NOS activation  
The differences in GFAP expression is more evidence of the differential response the 
DRN has in response to stress and provide evidence that astrocyte reactivity occurs more 
so in the rostral region than the caudal region despite the fact that the caudal region is 
more involved in the stress response.  We also show that length of restraint is significant 
as 6 hours of restraint increased GFAP density in both rostral and caudal regions.   
5.7 Future Directions 
 
This study added a temporal component to which showed that the length of 
restraint makes a difference in NOS activation.  While a 6 hour length of restraint may 





response reported here are for varying levels of acute stress. The fact that 6 hours of 
restraint showed decrease of NOS activation in the DRL needs to be further explored. It 
may have to do with some feedback from other NOS neurons or from a different 
transmitter altogether. Studying the fibers that innervate the region as well as the fibers 
projecting to other regions in response to stress would give a more complete picture on 
the role of NO because it is a modulatory molecule for other neurotransmitters.  
 The role of NOS in the DRN following chronic stress, which would be modeled 
by several consecutive days of acute restraint, would be an important next step to 
elucidate the role NO plays in a more debilitating type of stress. Also, NO is involved 
with decreasing the response by the sympathetic nervous system (SNS) and since the 
DRN is involved largely with modulating the autonomic nervous system it would be 
interesting to see if NO from the DRN is directly involved with the modulation of the 
SNS.   
Also these experiments measured the response immediately after stress has been 
applied.  It would be interesting to see the NOS response in the DRN following a delay 
after varying levels of acute or chronic restraint.  Following a week of survival, if the 
NOS activation is changed because of behavioral differences, this would be considered a 
model for post traumatic stress disorder.   
The projections of NOS neurons from the DRN are not well known, especially to 
structures involved in the stress paradigm.  Future studies that show the projection path of 
NOS neurons to the hypothalamus would be very beneficial to help complete the picture 





Lastly, the mechanism of increased activation of NOS in the DRN during stress is 
not known. Arginine may either come from blood vessels via CATs or it may be recycled 
from citrulline. Since reports show that increasing l-arginine in the DRN results in anti-
depressant like behaviors it is likely that there is involvement with arginine transport 
through CATs.  Although we did not conclude that from these experiments, it would be 










These experiments together support already substantial evidence that subregions 
of the DRN are differentially involved in the process of stress signaling. It also shows 
that the temporal profile of the DRN is changed over a 6 hour period in regards to both 
astrocytes and NOS activation. Using NADPH-d as a marker for NOS activation we were 
able to show that DRN NOS activation in cell bodies and fibers is not only spatially 
differentiated across the DRN but there are differences in the temporal response of NOS 
activation following acute stress as well. 
Immunohistochemistry using GFAP revealed that astrocytes in the rostral DRN 
were more active in response to stress than those of the caudal DRN. It also showed that 
6 hours of restraint stimulate astrocyte activation in both rostral and caudal DRN. These 
experiments further support that DRN is a highly complex structure and its topography is 
important in how it processes stress.  
These findings are important and should be taken into consideration when 
therapies for stress are developed. The DRN may be a candidate for drug target therapy 
since studies show that NO produced there has antidepressant like effects, but a timed 






  1. Himmerich, H.; Zimmermann, P.; Ising, M.; Kloiber, S.; Lucae, S.; Kunzel, H. E.; 
Binder, E. B.; Holsboer, F.; Uhr, M. Changes in the hypothalamic-pituitary-
adrenal axis and leptin levels during antidepressant treatment. 
Neuropsychobiology 2007, 55 (1), 28-35. 
 
  2. Price, M. L.; Lucki, I. Regulation of serotonin release in the lateral septum and 
striatum by corticotropin-releasing factor. J Neurosci. 2001, 21 (8), 2833-41. 
 
  3. Abrams, J. K.; Johnson, P. L.; Hollis, J. H.; Lowry, C. A. Anatomic and functional 
topography of the dorsal raphe nucleus. Ann N Y Acad Sci. 2004, 1018, 46-57. 
 
  4. Lowry, C. A. Functional subsets of serotonergic neurones: implications for control 
of the hypothalamic-pituitary-adrenal axis. J Neuroendocrinol. 2002, 14 (11), 
911-23. 
 
  5. Harkin, A.; Connor, T. J.; Walsh, M.; St John, N.; Kelly, J. P. Serotonergic 
mediation of the antidepressant-like effects of nitric oxide synthase inhibitors. 
Neuropharmacology 2003, 44 (5), 616-23. 
 
  6. Spiacci, A., Jr.; Coimbra, N. C.; Zangrossi, H., Jr. Differential involvement of 
dorsal raphe subnuclei in the regulation of anxiety- and panic-related 
defensive behaviors. Neuroscience 2012, 227, 350-60. 
 
  7. Vasudeva, R. K.; Lin, R. C.; Simpson, K. L.; Waterhouse, B. D. Functional 
organization of the dorsal raphe efferent system with special consideration of 
nitrergic cell groups. J Chem Neuroanat. 2011, 41 (4), 281-93. 
 
  8. Silva, M.; Aguiar, D. C.; Diniz, C. R.; Guimaraes, F. S.; Joca, S. R. Neuronal NOS 
inhibitor and conventional antidepressant drugs attenuate stress-induced fos 
expression in overlapping brain regions. Cell Mol Neurobiol. 2012, 32 (3), 
443-53. 
 
  9. Racagni, G.; Popoli, M. Cellular and molecular mechanisms in the long-term action 
of antidepressants. Dialogues Clin Neurosci. 2008, 10 (4), 385-400. 
 
10.  Xu, Z. Q.; Hokfelt, T. Expression of galanin and nitric oxide synthase in 
subpopulations of serotonin neurons of the rat dorsal raphe nucleus. J Chem 





11.  Okere, C. O.; Waterhouse, B. D. Activity-dependent heterogeneous  populations of 
nitric oxide synthase neurons in the rat dorsal raphe nucleus. Brain Res. 2006, 
1086.  
 
12.  Vasudeva, B. D. W. Cellular Profile of the Dorsal Raphe Lateral Wing Sub-Region: 
Relationship to the Lateral Dorsal Tegmental Nucleus. Journal of Chemical 
Neuroanatomy 2014, 57-58. 
 
13.  Okere C. O.; Waterhouse, B. D. Acute Restraint Increases NADPH-diaphorase 
Staining in Distinct Subrgions of the Rat Dorsal Raphe Nucleus: Implications 
for Raphe Serotonergic and Nitrergic Transmission. Brain Res. 2006, 1119. 
 
14.  Spiacci, A., Jr.; F. K., F. S. Guimaraes, R. M. W. Oliveira, Nitric oxide-mediated 
anxiolytic-like and antidepressant-like effects in animal models of anxiety and 
depression. Pharmacology Biochemistry and Behav. 2008, 88, 247-255. 
 
15.  Okere, C. O.; Waterhouse, B. D. Acute restraint increases NADPH-diaphorase 
staining in distinct subregions of the rat dorsal raphe nucleus: implications for 
raphe serotonergic and nitrergic transmission. Brain Res. 2006, 1119 (1), 174-
81. 
 
16.  Spiacci, A., Jr.; Kanamaru, F.; Guimaraes, F. S.; Oliveira, R. M. Nitric oxide-
mediated anxiolytic-like and antidepressant-like effects in animal models of 
anxiety and depression. Pharmacol Biochem Behav. 2008, 88 (3), 247-55. 
 
17.  Spiacci, A., Jr.; Coimbra, N. C.; Zangrossi, N. C., Jr. Differential involvement of 
dorsal raphe subnuclei in the regulation of anxiety- and panic- related 
defensive behaviors. Neuroscience 2012, 350-360. 
 
18.  Wang, Q. -P.; Nakai, Y. The dorsal raphe: an important nucleus in pain modulation. 
Brain Res. 1994, 34, 575-585. 
 
19.  Burlet, S.; Leger, L.; Cespuglio, R. Nitric oxide and sleep in the rat: a puzzling 
relationship. Neuroscience 1999, 92 (2), 627-39. 
 
20.  Shikanai, H.; Yoshida, T.; Konno, K.; Yamasaki, M.; Izumi, T.; Ohmura, Y.; 
Watanabe, M.; Yoshioka, M. Distinct neurochemical and functional properties 
of GAD67-containing 5-HT neurons in the rat dorsal raphe nucleus. J 
Neurosci. 2012, 32 (41), 14415-26. 
 
21.  Ferre, S.; Artigas, F. Dopamine D2 receptor-mediated regulation of serotonin 
extracellular concentration in the dorsal raphe nucleus of freely moving rats. J 






22.  Kirifides, M. L.; Simpson, K. L.; Lin, R. C.; Waterhouse, B. D. Topographic 
organization and neurochemical identity of dorsal raphe neurons that project 
to the trigeminal somatosensory pathway in the rat. J Comp Neurol. 2001, 435 
(3), 325-40. 
 
23.  Vertes, R. P. A PHA-L analysis of ascending projections of the dorsal raphe 
nucleus in the rat. J Comp Neurol. 1991, 313 (4), 643-68. 
 
24.  Fuxe, K.; Hokfelt, T.; Olson, L.; Ungerstedt, U. Central monoaminergic pathways 
with emphasis on their relation to the so called "extrapyramidal motor 
system." Pharmacol Ther B. 1977, 3 (2), 169-210. 
 
25.  Jacobs, B. L.; Azmitia, E. C. Structure and function of the brain serotonin system. 
Physiol Rev. 1992, 72 (1), 165-229. 
 
26.  Lee, S. B.; Chang, B. J.; Lee, H. S. Organization of histamine-immunoreactive, 
tuberomammillary neurons projecting to the dorsal tier of the substantia nigra 
compacta in the rat. Brain Res. 2008, 1203, 79-88. 
 
27.  O'Hearn, E.; Molliver, M. E. Organization of raphe-cortical projections in rat: a 
quantitative retrograde study. Brain Res Bull. 1984, 13 (6), 709-26. 
 
28.  Waselus, M.; Galvez, J. P.; Valentino, R. J.; Van Bockstaele, E. J. Differential 
projections of dorsal raphe nucleus neurons to the lateral septum and striatum. 
J Chem Neuroanat. 2006, 31 (4), 233-42. 
 
29.  Evans, A. K.; Heerkens, J. L.; Lowry, C. A. Acoustic stimulation in vivo and 
corticotropin-releasing factor in vitro increase tryptophan hydroxylase activity 
in the rat caudal dorsal raphe nucleus. Neurosci Lett. 2009, 455 (1), 36-41. 
 
30.  Matthews, P. R.; Harrison, P. J. A morphometric, immunohistochemical, and in situ 
hybridization study of the dorsal raphe nucleus in major depression, bipolar 
disorder, schizophrenia, and suicide. J Affect Disord. 2012, 137 (1-3), 125-34. 
 
31.  Lopez-Figueroa, M. O.; Day, H. E.; Akil, H.; Watson, S. J. Nitric oxide in the stress 
axis. Histol Histopathol. 1998, 13 (4), 1243-52. 
 
32.  Ruben Zamora, Y. V.; Billiar, Timothy R. Inducible Nitric Oxide and Inflammatory 
Diseases. Molecular Medicine 2000, 6 (5). 
 
33.  Yun-Li Peng, Y.-N. L.; Lei-Liu, Xia Wang; Chun-Lei Jiang; Yun-Xia Wang. 
Inducible nitric oxide synthase is involved in the modulation of depressive 
behaviors induced by unpredictable chronic mild stress. Journal of 






34.  Forstermann, U.; Kleinert, H. Nitric oxide synthase: expression and expressional 
control of the three isoforms. Naunyn Schmiedebergs Arch Pharmacol. 1995, 
352 (4), 351-64. 
 
35.  Prast, H.; Philippu, A. Nitric oxide as modulator of neuronal function. Prog 
Neurobiol. 2001, 64 (1), 51-68. 
 
36.  Hope, B. T.; Michael, G. J.; Knigge, K. M.; Vincent, S. R. Neuronal NADPH 
diaphorase is a nitric oxide synthase. Proceedings of the National Academy of 
Sciences of the United States of America 1991, 88 (7), 2811-4.  
 
37.  Paul, V.; Ekambaram, P. Involvement of nitric oxide in learning & memory 
processes. Indian J Med Res. 2011, 133, 471-8. 
 
38.  Pogun, S.; Kuhar, M. J. Regulation of neurotransmitter reuptake by nitric oxide. 
Ann N Y Acad Sci. 1994, 738, 305-15. 
 
39.  Li, Y.; Zhang, W.; Stern, J. E. Nitric oxide inhibits the firing activity of 
hypothalamic paraventricular neurons that innervate the medulla oblongata: 
role of GABA. Neuroscience 2003, 118 (3), 585-601. 
 
40.  Kopincova, J.; Puzserova, A.; Bernatova, I. Biochemical aspects of nitric oxide 
synthase feedback regulation by nitric oxide. Interdiscip Toxicol. 2011, 4 (2), 
63-8. 
 
41.  Hurshman, A. R.; Marletta, M. A. Nitric oxide complexes of inducible nitric oxide 
synthase: spectral characterization and effect on catalytic activity. 
Biochemistry 1995, 34 (16), 5627-34. 
 
42.  Abu-Soud, H. M.; Wang, J.; Rousseau, D. L.; Fukuto, J. M.; Ignarro, L. J.; Stuehr, 
D. J. Neuronal nitric oxide synthase self-inactivates by forming a ferrous-
nitrosyl complex during aerobic catalysis. J Biol Chem. 1995, 270 (39), 
22997-3006. 
 
43.  Santolini, J.; Meade, A. L.; Stuehr, D. J. Differences in three kinetic parameters 
underpin the unique catalytic profiles of nitric-oxide synthases I, II, and III. J 
Biol Chem. 2001, 276 (52), 48887-98. 
 
44.  Grumbach, I. M.; Chen, W.; Mertens, S. A.; Harrison, D. G. A negative feedback 
mechanism involving nitric oxide and nuclear factor kappa-B modulates 







45.  Joca, S. R.; Guimaraes, F. S. Inhibition of neuronal nitric oxide synthase in the rat 
hippocampus induces antidepressant-like effects. Psychopharmacology (Berl). 
2006, 185 (3), 298-305. 
 
46.  Suzuki, E.; Yagi, G.; Nakaki, T.; Kanba, S.; Asai, M. Elevated plasma nitrate levels 
in depressive states. J Affect Disord. 2001, 63 (1-3), 221-4. 
 
47.  Yanik, M.; Vural, H.; Tutkun, H.; Zoroglu, S. S.; Savas, H. A.; Herken, H.; 
Kocyigit, A.; Keles, H.; Akyol, O. The role of the arginine-nitric oxide 
pathway in the pathogenesis of bipolar affective disorder. Eur Arch Psychiatry 
Clin Neurosci. 2004, 254 (1), 43-7. 
 
48.  Tomaz, V. S.; Cordeiro, R. C.; Costa, A. M.; de Lucena, D. F.; Nobre Junior, H. V.; 
de Sousa, F. C.; Vasconcelos, S. M.; Vale, M. L.; Quevedo, J.; Macedo, D. 
Antidepressant-like effect of nitric oxide synthase inhibitors and sildenafil 
against lipopolysaccharide-induced depressive-like behavior in mice. 
Neuroscience 2014, 268, 236-46. 
 
49.  Akyol, O.; Zoroglu, S. S.; Armutcu, F.; Sahin, S.; Gurel, A. Nitric oxide as a 
physiopathological factor in neuropsychiatric disorders. In Vivo. 2004, 18 (3), 
377-90. 
 
50.  Savas, H. A.; Herken, H.; Yurekli, M.; Uz, E.; Tutkun, H.; Zoroglu, S. S.; Ozen, M. 
E.; Cengiz, B.; Akyol, O. Possible role of nitric oxide and adrenomedullin in 
bipolar affective disorder. Neuropsychobiology 2002, 45 (2), 57-61. 
 
51.  Karson, C. N.; Griffin, W. S.; Mrak, R. E.; Husain, M.; Dawson, T. M.; Snyder, S. 
H.; Moore, N. C.; Sturner, W. Q. Nitric oxide synthase (NOS) in 
schizophrenia: increases in cerebellar vermis. Mol Chem Neuropathol. 1996, 
27 (3), 275-84. 
 
52.  Das, I.; Khan, N. S.; Puri, B. K.; Sooranna, S. R.; de Belleroche, J.; Hirsch, S. R. 
Elevated platelet calcium mobilization and nitric oxide synthase activity may 
reflect abnormalities in schizophrenic brain. Biochem Biophys Res Commun. 
1995, 212 (2), 375-80. 
 
53.  Ayers, N. A.; Kapas, L.; Krueger, J. M. Circadian variation of nitric oxide synthase 
activity and cytosolic protein levels in rat brain. Brain Res. 1996, 707 (1), 
127-30. 
 
54.  Perge, J. A.; Niven, J. E.; Mugnaini, E.; Balasubramanian, V.; Sterling, P. Why do 
axons differ in caliber? J Neurosci. 2012, 32 (2), 626-38. 
 
55.  Burnstock, G. Non-synaptic transmission at autonomic neuroeffector junctions. 





56.  Zhang, Z. W.; Kang, J. I.; Vaucher, E. Axonal varicosity density as an index of 
local neuronal interactions. PLoS One. 2011, 6 (7), e22543. 
 
57.  Vizi, E. S. Role of high-affinity receptors and membrane transporters in 
nonsynaptic communication and drug action in the central nervous system. 
Pharmacol Rev. 2000, 52 (1), 63-89. 
 
58.  Smalls, S. L.; Okere, C. O. Acute restraint increases varicosity density and reduces 
the inter-varicosity distance in NADPH diaphorase-containing neurons in the 
rat dorsolateral periaqueductal gray matter. Neurosci Lett. 2012, 511 (1), 23-7. 
 
59.  Wood, J.; Garthwaite, J. Models of the diffusional spread of nitric oxide: 
implications for neural nitric oxide signalling and its pharmacological 
properties. Neuropharmacology 1994, 33 (11), 1235-44. 
 
60.  Miller, Lyle H.; Smith, Alma D.; Rothstein, Larry. The Stress Solution: An Action 
Plan to Manage the Stress in Your Life reprint ed.; Pocket Books: 1994; p 
448. 
 
61.  Dallman, M. F. Stress-induced obesity and the emotional nervous system. Trends in 
Endocrinology and Metabolism 2010, 21 (3), 159-165. 
 
62.  Steptoe, A. Diabetes: Stress resilience and risk of type 2 diabetes mellitus. Nat Rev 
Endocrinol. 2016, 12 (4), 189-90. 
 
63.  Cohen, L.; Cole, S. W.; Sood, A. K.; Prinsloo, S.; Kirschbaum, C.; Arevalo, J. M.; 
Jennings, N. B.; Scott, S.; Vence, L.; Wei, Q.; Kentor, D.; Radvanyi, L.; 
Tannir, N.; Jonasch, E.; Tamboli, P.; Pisters, L. Depressive symptoms and 
cortisol rhythmicity predict survival in patients with renal cell carcinoma: role 
of inflammatory signaling. PLoS One. 2012, 7 (8), e42324. 
 
64.  Gold, P. W. The organization of the stress system and its dysregulation in 
depressive illness. Mol Psychiatry. 2015, 20 (1), 32-47. 
 
65.  Kubo, T.; Kanaya, T.; Numakura, H.; Okajima, H.; Hagiwara, Y.; Fukumori, R. 
The lateral septal area is involved in mediation of immobilization stress-
induced blood pressure increase in rats. Neurosci Lett. 2002, 318 (1), 25-8. 
 
66.  Sevgi, S.; Ozek, M.; Eroglu, L. L-NAME prevents anxiety-like and depression-like 
behavior in rats exposed to restraint stress. Methods Find Exp Clin 
Pharmacol. 2006, 28 (2), 95-9. 
 
67.  Padovan, C. M.; Guimaraes, F. S. Restraint-induced hypoactivity in an elevated 






68.  Buynitsky, T.; Mostofsky, D. I. Restraint stress in biobehavioral research: Recent 
developments. Neurosci Biobehav Rev. 2009, 33 (7), 1089-98. 
 
69.  Jackson, M. E.; Moghaddam, B. Distinct patterns of plasticity in prefrontal cortex 
neurons that encode slow and fast responses to stress. Eur J Neurosci. 2006, 
24 (6), 1702-10. 
 
70.  Dal-Zotto, S.; Marti, O.; Delgado, R.; Armario, A., Potentiation of glucocorticoid 
release does not modify the long-term effects of a single exposure to 
immobilization stress. Psychopharmacology  2004, 177 (1-2), 230-7. 
 
71.  Haas, D. A.; George, S. R. Single or repeated mild stress increases synthesis and 
release of hypothalamic corticotropin-releasing factor. Brain Res. 1988, 461 
(2), 230-7. 
 
72.  Smith, M. I. Acute Restraint Stress-Induced Spatio-Temporal Activation of 
Neurons in Discrete Subregions of th Adult Male Rat Brain. Clark Atlanta 
University: 2014. 
 
73.  Miller, R. H.; Raff, M. C. Fibrous and protoplasmic astrocytes are biochemically 
and developmentally distinct. J Neurosci. 1984, 4 (2), 585-92. 
 
74.  Bailey, M. S.; Shipley, M. T. Astrocyte subtypes in the rat olfactory bulb: 
morphological heterogeneity and differential laminar distribution. J Comp 
Neurol. 1993, 328 (4), 501-26. 
 
75.  Anderson, C. M.; Swanson, R. A. Astrocyte glutamate transport: review of 
properties, regulation, and physiological functions. Glia  2000, 32 (1), 1-14. 
 
76.  Simpson, I. A.; Carruthers, A.; Vannucci, S. J. Supply and demand in cerebral 
energy metabolism: the role of nutrient transporters. J Cereb Blood Flow 
Metab. 2007, 27 (11), 1766-91. 
 
77.  Abbott, N. J. Astrocyte-endothelial interactions and blood-brain barrier 
permeability. J Anat. 2002, 200 (6), 629-38. 
 
78.  Ben Haim, L.; Carrillo-de Sauvage, M. A.; Ceyzeriat, K.; Escartin, C. Elusive roles 
for reactive astrocytes in neurodegenerative diseases. Front Cell Neurosci. 
2015, 9, 278. 
 
79.  Eddleston, M.; Mucke, L. Molecular profile of reactive astrocytes--implications for 






80.  McElhaney, M. R.; Chandler, L. J.; Streit, W. J. Astrocytes but not microglia 
express NADPH-diaphorase activity after motor neuron injury in the rat. 
Neurosci Lett. 1994, 180 (1), 67-70. 
 
81.  Lambert, K. G.; Gerecke, K. M.; Quadros, P. S.; Doudera, E.; Jasnow, A. M.; 
Kinsley, C. H. Activity-stress increases density of GFAP-immunoreactive 
astrocytes in the rat hippocampus. Stress 2000, 3 (4), 275-84. 
 
82.  O'Kane, R. L.; Vina, J. R.; Simpson, I.; Zaragoza, R.; Mokashi, A.; Hawkins, R. A. 
Cationic amino acid transport across the blood-brain barrier is mediated 
exclusively by system y+. Am J Physiol Endocrinol Metab. 2006, 291 (2), 
E412-9. 
 
83.  Gensert, J. M.; Ratan, R. R., The metabolic coupling of arginine metabolism to 
nitric oxide generation by astrocytes. Antioxid Redox Signal. 2006, 8 (5-6), 
919-28. 
 
84.  Braissant, O.; Gotoh, T.; Loup, M.; Mori, M.; Bachmann, C. L-arginine uptake, the 
citrulline-NO cycle and arginase II in the rat brain: an in situ hybridization 
study. Brain Res Mol Brain Res. 1999, 70 (2), 231-41. 
 
85.  Arnt-Ramos, L. R.; O'Brien, W. E.; Vincent, S. R. Immunohistochemical 
localization of argininosuccinate synthetase in the rat brain in relation to nitric 
oxide synthase-containing neurons. Neuroscience 1992, 51 (4), 773-89. 
 
86.  Hosokawa, H.; Ninomiya, H.; Sawamura, T.; Sugimoto, Y.; Ichikawa, A.; Fujiwara, 
K.; Masaki, T. Neuron-specific expression of cationic amino acid transporter 
3 in the adult rat brain. Brain Res. 1999, 838 (1-2), 158-65. 
 
87.  Braissant, O.; Gotoh, T.; Loup, M.; Mori, M.; Bachmann, C. Differential expression 
of the cationic amino acid transporter 2(B) in the adult rat brain. Brain Res 
Mol Brain Res. 2001, 91 (1-2), 189-95. 
 
88.  Jager, K.; Wolf, S.; Dobrowolny, H.; Steiner, J.; Nave, H.; Maronde, E.; Bogerts, 
B.; Bernstein, H. G. Differential topochemistry of three cationic amino acid 
transporter proteins, hCAT1, hCAT2 and hCAT3, in the adult human brain. 
Amino Acids 2013, 44 (2), 423-33. 
 
89.  Segieth, J.; Fowler, L.; Whitton, P. S.; Pearce, B. Arginine release from rat 
cerebellar astrocytes: autocrine roles for glutamate and nitric oxide? Neurosci 
Lett. 2004, 372 (3), 262-5. 
 
90.  Aoki, E.; Semba, R.; Mikoshiba, K.; Kashiwamata, S. Predominant localization in 
glial cells of free L-arginine. Immunocytochemical evidence. Brain Res. 1991, 





91.  Kharazia, V. N.; Petrusz, P.; Weinbert, R. J.; Rustioni, A. Arginine and NADPH 
diaphorase in the rat ventroposterior thalamic nucleus. Brain Res. 1997, 744 
(1), 151-155.   
 
92.  Do, K. Q.; Grima, G.; Benz, B.; Salt, T. E. Glial-neuronal transfer of arginine and 
S-nitrosothiols in nitric oxide transmission. Ann N Y Acad Sci. 2002, 962, 81-
92. 
 
93.  Halberstadt, A. L.; Balaban, C. D. Selective anterograde tracing of nonserotonergic 
projections from dorsal raphe nucleus to the basal forebrain and extended 
amygdala. J Chem Neuroanat. 2008, 35 (4), 317-25. 
 
94.  Lee, H. S.; Kim, M. A.; Valentino, R. J.; Waterhouse, B. D. Glutamatergic afferent 
projections to the dorsal raphe nucleus of the rat. Brain Res. 2003, 963 (1-2), 
57-71. 
 
